Blood protein levels may reveal ICU patient prognosis
NCT ID NCT07414160
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 500 critically ill adults in the ICU to see if changes in a blood protein called prealbumin can predict who will die or get infections. Researchers will track prealbumin levels over time and compare them to patient outcomes. No new treatment is given—participants receive standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better monitor nutrition in ICU patients and identify those at higher risk of poor outcomes.
- What could go wrong
- This is an observational study, not a treatment trial. It may find no clear link between prealbumin changes and patient outcomes, or the results may not apply to all ICU patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- Can a 4-Hour video course sharpen Nurses' ability to detect delirium in the ICU?
- A gentle touch from family may calm the ICU storm
- What does a healthy mouth mean for people with disabilities?